Response Biomedical – RAMP 200
The RAMP® 200 by Response Biomedical is a cutting-edge point-of-care device designed to streamline acute care diagnostic testing.
The RAMP® 200 by Response Biomedical is a cutting-edge point-of-care device designed to streamline acute care diagnostic testing.
Every day more and more newborns are screened worldwide for metabolic and endocrine disorders. Although screening for haemoglobin has a long history in some countries (USA or UK), in other countries it is a recent addition to their screening panels (Portugal; Germany).
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Linearity and calibration verification– confirmation of test stability throughout reportable ranges with VALIDATE® from Maine Standards.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
C-reactive protein (CRP) is a widely used analyte in healthcare, but do you know why it’s beneficial to measure CRP using point-of-care (POC) testing?
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Haemoglobinopathies, such as sickle cell disease and alpha/beta thalassemia major, are prevalent genetic disorders that affect the protein part of haemoglobin (Hb).
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
VALIDATE® Hemostatsis – Linearity and Calibration Verification Test Kits for Clinical Analysers
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Sebia FLC Kappa and Sebia FLC Lambda – Measurement of FLC can be complex and challenging for many laboratories using traditional turbidimetric or nephelometric methods.
Products are for professional/laboratory use only.
IDS cartilage markers, supporting early identification of cartilage damage by providing dynamic assessment of cartilage destruction.
Products are for professional/laboratory use only.
Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge.
Urinary C-terminal crosslinked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers.